Alpha Cognition (ACOG) Notes Payables (2023 - 2024)
Alpha Cognition's (ACOG) quarterly Notes Payables came in at $911463.0 in Q4 2024, down 24.76% year-on-year from $1.2 million in Q1 2024, and down 24.76% quarter-over-quarter from $1.2 million in Q3 2024.
Alpha Cognition (ACOG) Notes Payables (2023 - 2024) Analysis & Trends
Alpha Cognition's Notes Payables history runs 2 years deep, the most recent figure standing at $911463.0 for Q4 2024.
- On a quarterly basis, Notes Payables fell 24.76% year-over-year to $911463.0 in Q4 2024; TTM through Dec 2024 was $911463.0, a 24.76% decrease from a year earlier, with the FY2024 full-year figure at $911463.0, down 24.76% from the prior year.
- Notes Payables eased to $911463.0 in Q4 2024 per ACOG's latest filing, from $1.2 million in the prior quarter.
- Across five years, Notes Payables topped out at $1.2 million in Q4 2023 and bottomed at $300000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Alpha Cognition | 145.51 Mn | 79.41 Mn | 2.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 911,463.00 |
| Sep 30, 2024 | 1.21 Mn |
| Jun 30, 2024 | 300,000.00 |
| Dec 31, 2023 | 1.21 Mn |